首页> 外文OA文献 >High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II–IIIA breast cancer

【2h】

High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II–IIIA breast cancer

机译：与Paclitaxel Plus菲拉特组合给予的高剂量表皮蛋白在与紫杉醇加上菲格拉特组合给予有效动员方案，以支持高剂量浓度的高风险阶段IIIA-IIIA乳腺癌患者的三种疗程

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
U De Giorgi; G Rosti; A Zaniboni; M Ballardini; M R Minzi; M Baioni; E Ferrari; L Zornetta; M Marangolo;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast canc [J] . De Giorgi U, Rosti G, Zaniboni A, Bone marrow transplantation . 2003,第3期

机译：高剂量表柔比星联合右雷佐生，与紫杉醇联合非格司亭联合使用可为高危II-IIIA期乳癌患者提供有效的动员方案，以支持三疗程的大剂量密集化疗
2. Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer. [J] . De Giorgi U, Giannini M, Frassineti L, International Journal of Radiation Oncology, Biology, Physics . 2006,第4期

机译：在高剂量II-III期乳腺癌高危患者中进行表柔比星大剂量密集化疗后放疗，然后使用右雷佐生和紫杉醇进行放疗的可行性。
3. Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-up. [J] . Basser RL, To LB, Collins JP, Journal of Clinical Oncology . 1999,第1期

机译：II期或III期高危乳腺癌妇女的多周期大剂量化疗和非格司亭动员的外周血祖细胞：五年随访。
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease) [O] . E C J Phernambucq, B Biesma, E F Smit, 2006

机译：多中心II期加速顺铂和大剂量表柔比星联合手术或放疗的IIIa期非小细胞肺癌纵隔淋巴结受累（N2-疾病）患者的试验
6. Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00 [O] . G. Fountzilas, U. Dafni, H. Gogas, 2008

机译：高风险乳腺癌患者的术后剂量 - 致密顺序化疗，高风险乳腺癌患者：Hellenic合作肿瘤学院的安全分析随机分配III审判他10/00

High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II–IIIA breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅